ACCENTMICPharmaceuticals
ACCENTMICST — Cash Flow Statement
₹267.00
+0.00%
ACCENTMICST Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | -1.99 Cr | 3.50 Cr | 11.00 Cr | -0.11 Cr |
| Repayment Of Debt | -10.02 Cr | -3.40 Cr | -15.89 Cr | -4.65 Cr |
| Issuance Of Debt | 0.00 | 2.11 Cr | 9.35 Cr | 5.37 Cr |
| Issuance Of Capital Stock | 84.27 Cr | 0.13 Cr | 0.00 | 0.00 |
| Capital Expenditure | -13.32 Cr | -4.08 Cr | -3.87 Cr | -5.15 Cr |
| End Cash Position | 1.58 Cr | 0.31 Cr | 1.10 Cr | 0.20 Cr |
| Beginning Cash Position | 0.31 Cr | 1.10 Cr | 0.20 Cr | 3.62 Cr |
| Changes In Cash | 1.26 Cr | -0.79 Cr | 0.90 Cr | -3.42 Cr |
| Financing Cash Flow | 72.27 Cr | -4.32 Cr | -9.67 Cr | -2.19 Cr |
| Interest Paid Cff | -0.94 Cr | -2.13 Cr | -2.69 Cr | -2.90 Cr |
| Cash Dividends Paid | -1.04 Cr | -1.03 Cr | -0.43 Cr | — |
| Common Stock Dividend Paid | -1.04 Cr | -1.03 Cr | -0.43 Cr | 0.00 |
| Net Common Stock Issuance | 84.27 Cr | 0.13 Cr | 0.00 | 0.00 |
| Common Stock Issuance | 84.27 Cr | 0.13 Cr | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -10.02 Cr | -1.28 Cr | -6.54 Cr | 0.71 Cr |
| Net Long Term Debt Issuance | -10.02 Cr | -1.28 Cr | -6.54 Cr | 0.71 Cr |
| Long Term Debt Payments | -10.02 Cr | -3.40 Cr | -15.89 Cr | -4.65 Cr |
| Long Term Debt Issuance | 0.00 | 2.11 Cr | 9.35 Cr | 5.37 Cr |
| Investing Cash Flow | -82.34 Cr | -4.04 Cr | -4.30 Cr | -6.27 Cr |
| Net Other Investing Changes | 1000.00 | -1000.00 | — | 1000.00 |
| Interest Received Cfi | 0.16 Cr | 0.05 Cr | 0.06 Cr | 0.08 Cr |
| Net Investment Purchase And Sale | -69.18 Cr | -95000.00 | -0.52 Cr | -1.20 Cr |
| Net PPE Purchase And Sale | -13.32 Cr | -4.08 Cr | -3.87 Cr | -5.15 Cr |
| Purchase Of PPE | -13.32 Cr | -4.08 Cr | -3.87 Cr | -5.15 Cr |
| Operating Cash Flow | 11.33 Cr | 7.57 Cr | 14.87 Cr | 5.04 Cr |
| Taxes Refund Paid | -6.08 Cr | -2.54 Cr | -1.66 Cr | -1.19 Cr |
| Change In Working Capital | -24.87 Cr | -10.80 Cr | 2.19 Cr | -2.94 Cr |
| Change In Other Current Liabilities | 5.08 Cr | -0.10 Cr | 2.96 Cr | 2.81 Cr |
| Change In Other Current Assets | -0.27 Cr | -0.16 Cr | 0.00 | 0.00 |
| Change In Payable | -14.53 Cr | 4.49 Cr | 11.78 Cr | -0.65 Cr |
| Change In Inventory | 8.96 Cr | -14.05 Cr | -8.03 Cr | -13.36 Cr |
| Change In Receivables | -24.83 Cr | -1.33 Cr | -4.75 Cr | 7.65 Cr |
| Other Non Cash Items | -0.73 Cr | 2.24 Cr | 2.60 Cr | -0.46 Cr |
| Provisionand Write Offof Assets | 0.21 Cr | 0.00 | 0.00 | 0.00 |
| Depreciation And Amortization | 4.43 Cr | 4.11 Cr | 4.15 Cr | 3.55 Cr |
| Amortization Cash Flow | 0.01 Cr | 0.04 Cr | 0.12 Cr | 0.12 Cr |
| Depreciation | 4.42 Cr | 4.11 Cr | 4.03 Cr | 3.43 Cr |
| Net Foreign Currency Exchange Gain Loss | -0.21 Cr | -0.08 Cr | — | — |
| Net Income From Continuing Operations | 36.53 Cr | 14.80 Cr | 7.59 Cr | 6.00 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | -1000.00 | — |
| Net Other Financing Charges | — | -1000.00 | 1000.00 | — |
| Gain Loss On Investment Securities | — | — | 2000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on ACCENTMICST
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.